Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ismigen for Allergic Rhinitis in Children
NCT04802616Phase 3Completed
- Sponsor
- Medical University of Lublin
- Start
- Mar 2021
- Primary completion
- Sep 2021
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of polyvalent mechanical bacterial lysate in allergic rhinitis (AR), sponsored by Medical University of Lublin. Started Mar 2021; status: completed.
02
Drugs
polyvalent mechanical bacterial lysate
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT04802616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04802616.